← Back to headlines
Merck's HIV Drug Regimen Idvynso Receives Approval
Pharmaceutical company Merck has secured approval for its new HIV drug regimen, Idvynso, marking a significant development in HIV treatment options.
21 Apr, 21:52 — 21 Apr, 21:52
Sources
Showing 1 of 1 sources
